Ionis Pharmaceuticals advances innovative treatments, including the newly approved Hibsago for Hepatitis B, highlighting breakthroughs in biotech and antivirals.
United States Greenlights Hibsago: A Breakthrough Hepatitis B Treatment Offering Hope Beyond Antivirals